The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab (NIVO) + low-dose ipilimumab (IPI) as first-line (1L) therapy in microsatellite instability-high/DNA mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Clinical update.
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Pfizer; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Lilly; Merck Serono
Speakers' Bureau - Bristol-Myers Squibb; Lilly; Merck Serono; Roche; Servier
Research Funding - Amgen; Merck Serono
 
Vittorina Zagonel
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Merck
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Janssen; Pfizer; Roche
Travel, Accommodations, Expenses - Bayer; Merck; Roche
 
Eric Van Cutsem
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Roche; SERVIER
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst)
 
M. Luisa Limon
No Relationships to Disclose
 
Ka Yeung Mark Wong
Consulting or Advisory Role - Baxalta; Baxalta
Speakers' Bureau - Sirtex Medical
Travel, Accommodations, Expenses - MSD Oncology
 
Alain Hendlisz
Research Funding - Amgen; Roche; Sanofi; Teva
Travel, Accommodations, Expenses - Merck; Roche
 
Massimo Aglietta
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Merck; Novartis
Research Funding - AstraZeneca (Inst); PharmaMar
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; MERCK; tesaro
 
Pilar Garcia-Alfonso
No Relationships to Disclose
 
Bart Neyns
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Etherna; Merck Sharp & Dohme; Novartis; Pfizer/EMD Serono; Roche; Sanofi
Speakers' Bureau - Novartis
Research Funding - Merck KGaA (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
 
Dana Backlund Cardin
Consulting or Advisory Role - Abbvie; Rafael Pharmaceuticals
Research Funding - Advaxis (Inst); Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); EMD Serono (Inst); Incyte (Inst); Lilly (Inst); Synta (Inst)
Travel, Accommodations, Expenses - Abbvie
 
Andrea Spallanzani
No Relationships to Disclose
 
Tomislav Dragovich
Employment - Taiho Pharmaceutical (I)
Research Funding - ARMO BioSciences; Berg Pharma; Bristol-Myers Squibb (Inst); Halozyme (Inst); Kyowa Hakko Kirin; Medivir; Rgenix
 
Usman Shah
No Relationships to Disclose
 
Ajlan Atasoy
No Relationships to Disclose
 
Jean-Marie Ledeine
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Michael J. Overman
Consulting or Advisory Role - Bristol-Myers Squibb; Gritstone Bio; MedImmune; Roche/Genentech
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Roche